Defosbarasertib

N/A

Report date: 2025/05/30 10:17:18
NME

Base Information

Drug NameDefosbarasertib
Drug Alias NameAZD2811 nanoparticleAZD-2811AZD-1152-HQPA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Aurora-B inhibitors
TargetsSerine/threonine-protein kinase Aurora-B
Therapy Area/IndicationsSolid tumoursSmall Cell Lung CarcinomaLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandAustralia +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca PlcBind Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsSolid tumoursLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A